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Abstract
Background: Several sub-Saharan African countries have rapidly scaled up the number of households that own insecticide-
treated mosquito nets (ITNs). Although the efficacy of ITNs in trials has been shown, evidence on their impact under routine
conditions is limited to a few countries and the extent to which the scale-up of ITNs has improved population health
remains uncertain.
Methods and Findings: We used matched logistic regression to assess the individual-level association between household
ITN ownership or use in children under 5 years of age and the prevalence of parasitemia among children using six malaria
indicator surveys (MIS) and one demographic and health survey. We used Cox proportional hazards models to assess the
relationship between ITN household ownership and child mortality using 29 demographic and health surveys. The pooled
relative reduction in parasitemia prevalence from random effects meta-analysis associated with household ownership of at
least one ITN was 20% (95% confidence interval [CI] 3%–35%; I
2=73.5%, p,0.01 for I
2 value). Sleeping under an ITN was
associated with a pooled relative reduction in parasitemia prevalence in children of 24% (95% CI 1%–42%; I
2=79.5%,
p,0.001 for I
2 value). Ownership of at least one ITN was associated with a pooled relative reduction in mortality between 1
month and 5 years of age of 23% (95% CI 13–31%; I
2=25.6%, p.0.05 for I
2 value).
Conclusions: Our findings across a number of sub-Saharan African countries were highly consistent with results from
previous clinical trials. These findings suggest that the recent scale-up in ITN coverage has likely been accompanied by
significant reductions in child mortality and that additional health gains could be achieved with further increases in ITN
coverage in populations at risk of malaria.
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Several sub-Saharan African countries, with support from
international donors, have rapidly scaled up the fraction of
households that own insecticide-treated mosquito nets (ITNs) from
essentially zero to above 60% over the last decade [1]. Although
there has been variable progress across countries, the push to
increase ITN coverage continues with more dramatic improve-
ments seen in the last few years [2].
The large expansion in the distribution of ITNs has been
motivated by evidence from cluster-randomized controlled trials
(RCTs) that showed pooled relative reductions in child mortality
of 18% [3] and parasite prevalence of 13% as a result of net use
[4]. There are several reasons why improvements in health
outcomes of the same magnitude might not be observed under
routine conditions [5]. These include, for example, reduced net
integrity and improper use. As a result, efforts should be made to
measure not only the coverage of ITNs, but also their impact on
health outcomes under real-world settings [6,7].
Evaluating the impact of malaria control strategies, including
the scale-up of ITNs on health outcomes, is difficult. Weak routine
health information and vital registration systems mean that it is
often not possible to accurately determine malaria-specific
mortality and morbidity. Evidence about the impact of ITNs
under routine conditions has been limited to selected studies such
as those conducted in rural Kenya [8], the Gambia [9], Tanzania
[10,11], and rural Somalia [12]. These studies, however, have
used different approaches to assess the relationship between ITNs
and health outcomes and represent only some of the countries
where ITN coverage has been scaled up.
In this paper, using routinely collected household surveys, we
demonstrate an approach to measure in a comparable way the
association between use and ownership of ITNs and parasitemia
prevalence and child mortality across a large number of countries
where ITNs have been distributed. This method quantifies the
impact of ITNs, under routine conditions, to allow a better
understanding of the effect on child health of the recent ITN
scale-up.
Methods
Data
We considered all demographic and health surveys (DHS) and
malaria indicator surveys (MIS) from sub-Saharan Africa countries
conducted since 2000 for which the unit-record data were
available. Prior to 2000, ITN ownership and use in sub-Saharan
Africa was universally low [13]. We included only surveys that
collected data on the health outcomes of interest (child mortality or
parasitemia prevalence) as well as information on ITN ownership
and use (including when the ITN was received or purchased, and
when it was retreated) and all covariates specified in the analyses.
We excluded the Ghana DHS conducted in 2003 as no child
deaths were observed in the small number of households that
owned ITNs. The results on the association between ITNs and
child mortality are based on 29 DHS in 22 sub-Saharan African
countries, while the results on the association between ITNs and
parasitemia prevalence are based on 6 MIS and one DHS from
seven sub-Saharan African countries.
Ownership and Use of ITNs
Mosquito nets were classified as conventional ITNs, which
require retreatment at least every year, or long-lasting
insecticide-treated mosquito nets (LLINs), which should be
replaced after 3 y [14]. While the data collection procedure
varied slightly across surveys, in general survey interviewers
visually confirmed presence of nets in the household and
recorded the following information for each net in a net roster:
how long ago it was acquired; brand, specifically, if it is an
LLIN; and for conventional ITNs, how long ago the net was last
treated. We considered a net to be an ITN if it was an LLIN
that was less than or equal to 3 y old or a conventional ITN that
was less than or equal to 1 y old or had been retreated in the last
year. The net roster was linked to the household roster and this
was used to identify which member slept under the net the
previous night.
Using this information, we estimated three variables of net
ownership and use, two at the household level and one at the child
(aged less than 5 y) level: (i) whether or not the household owned
an ITN, (ii) how many ITNs each household owned per household
member, and (iii) whether the child slept under an ITN the night
prior to the survey.
Health Outcomes
Parasitemia in children under the age of 5 y of age was
ascertained in surveys using a rapid diagnostic test (RDT) and/or
microscopy using thick or thin blood smears. Survey data and
documentation did not always indicate whether the positive result
was determined from RDT or microscopy.
Survival of children from age 1 mo to 59 mo was determined
from complete birth histories of women of reproductive age (15 to
49 y). We examined mortality between age 1 mo and 59 mo as
this is the same age period used in RCTs and previous
observational studies [4,8]; malaria deaths in the neonatal period
are very rare.
Malaria Transmission Intensity
All analyses controlled for the effect of malaria transmission
intensity. To determine malaria transmission intensity, we used
global positioning system (GPS) coordinates for each of the primary
sampling units (PSUs) in the MIS or DHS and linked this to data on
malaria transmission from the Malaria Atlas Project (http://www.
map.ox.ac.uk; [15]) using ArcGIS. All households in the PSU were
assigned the malaria transmission based on the PSU-level GPS
coordinates. We categorized malaria transmission intensity into the
following categories: (i) high transmission, defined as PfPR2–10 or P.
falciparum parasite rate (2 to 10 y) between 40%–100%; (ii) medium
transmission, defined as PfPR2–10 between 5%–40%; and (iii) low
transmission, defined as PfPR2–10 between 0%–5% [16]. Seven
DHS did not have PSU-level GPS coordinates available (Benin
2006, Congo 2005, Eritrea 2002, Niger 2006, Rwanda 2000, Sa ˜o
Tome ´ & Prı ´ncipe 2008, and Zambia 2001–2002). For these seven
surveys, households were assigned a malaria transmission category
on the basis of the average population-weighted parasite rate in the
province where the household was located.
Effect of ITN Ownership and Use in Children under 5 on
Parasitemia Prevalence
We examined the effect of ITN ownership and use on
parasitemia prevalence using exact matching. The literature on
the use of matching for causal inferences is sophisticated and
growing, and includes several applications in global health and
evaluations of health policies [17–21]. Matching provides a way of
preprocessing the data so that the treated group is as similar to the
control group as possible, thus making the treatment variable (in
this case, ITN ownership or ITN use) as independent of the
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the link between the treatment variable and the control variables,
matching makes estimates based on subsequent analyses less
dependent on model specification.
Within each survey, we exactly matched children who live in a
household that owns an ITN or children who slept under an ITN
the night prior to the survey to children from households without
an ITN on the basis of the following covariates: (i) age of the child
(0–1, 2–3, 4+ y); (ii) mother’s education (none, any); (ii) urban/
rural residence; and (iv) malaria transmission intensity. We
implemented the exact matching procedure using the MatchIt
software in R [22].
We then used logistic regression on the matched dataset to
provide added control of potential confounders using the following
covariates: (i) age of the child (0–1, 2–3, 4+ y); (ii) mother’s
education (none, primary, secondary or more); (iii) urban/rural
residence; (iv) household wealth quintile; (v) malaria transmission
intensity category; and (vi) wet or dry season at the time of the
survey. We estimated household wealth using information on asset
ownership [23–25].
A separate analysis was conducted for each survey and we
determined the odds ratio (OR) associated with ITN ownership or
use. We determined a pooled OR across all surveys using
DerSimonian-Laird random effects meta-analysis [26].
Effect of ITN Ownership on Child Mortality
We used complete birth history data from DHS to construct a
retrospective cohort that traces survival of children from age 1 mo
to 59 mo for the 3 y prior to the survey. From the household net
roster, using the information on when each net was acquired and/
or retreated, we determined household ownership of an ITN for
each month during the 3 y prior to the survey. As the surveys only
record use of ITNs for children who are alive at the time of the
survey, we were not able to study the relationship between ITN
use and child mortality.
We analyzed the relationship between household ownership of
ITNs and child mortality using Cox proportional hazards models
where analysis time was the age of the child in months. We
controlled for the following covariates: (i) maternal age (in 5-y age
groups); (ii) parity and birth interval (less than 12 mo, 12–23 mo,
greater or equal to 24 mo or first born); (iii) sex of the child; (iv)
single or multiple birth; (v) maternal education (no education, less
than primary, less than secondary, secondary or more); (vi)
household wealth quintile; (vii) urban/rural residence; (viii) skilled
birth attendance (SBA) coverage at the PSU level; (ix) three-dose
diphtheria, pertussis and tetanus (DPT3) immunization coverage
at the PSU-level; (x) calendar year; (xi) malaria transmission
intensity; and (xii) wet or dry season specific to the month of the
observation. Wet and dry seasons were determined from the
Mapping Malaria Risk in Africa project (http://www.mara.org.
za/).
A separate analysis was conducted for each survey and we
determined the relative risk (RR) of child mortality associated with
ITN ownership. We determined a pooled RR across all surveys
using DerSimonian-Laird random effects meta-analysis [26]. We
examined the sensitivity of the results to recall bias by restricting
the analysis to observations for just the one year prior to the
survey.
Effect of ITNs by Malaria Transmission Intensity, Number
of ITNs Owned, and Urban and Rural Residence
Malaria transmission varies considerably within countries and it
is likely that the effect of ITNs varies by transmission level. The
effect of ITN ownership may also vary according to the number of
ITNs owned by the household. Finally, the majority of RCTs and
observational studies of ITNs were conducted in rural areas and
the effect of ITNs in urban areas is less well characterized.
To test for these effects, we pooled individual observations from
all surveys and grouped observations by transmission intensity
(high, medium, and low), the number of ITNs owned per
household member (0, ,0.25 ITNs per household member,
$0.25 ITNs per household member), and urban or rural
residence. We ran separate models for each stratum. For the
analysis of child mortality, we included a random effect term
across surveys to capture systematic variation in the outcome
across surveys. We did not include this term for parasitemia
prevalence given the small number of surveys included.
All analyses were conducted in Stata 11 (Stata Corporation) and
R 2.9.2 (University of Auckland).
Results
Table 1 describes the characteristics of the 29 surveys included
in the analysis of child mortality; Table 2 provides information
about the seven surveys included in the analysis of parasitemia
prevalence. These surveys cover the majority of malaria-endemic
countries from sub-Saharan Africa with varying sized populations
at risk of malaria. ITN household ownership coverage at the time
of the survey ranged from less than 2% to almost 60% of
households.
Figure 1A shows the results of the analysis of the effect of
household ownership of at least one ITN on the prevalence of
parasitemia. Four countries demonstrated a statistically significant
association between ITN ownership and parasitemia prevalence:
Zambia with a 45% relative reduction in parasitemia prevalence
(95% confidence interval [CI] 22%–61%); Rwanda with a 45%
relative reduction (95% CI 7%–67%); Senegal with a 33% relative
reduction (95% CI 10%–50%); and Uganda with a 29% relative
reduction (95% CI, 13%–41%). Across the seven surveys, there
was a significant pooled reduction in parasitemia prevalence of
20% (95% CI 3%–35%) associated with household ownership of
an ITN. There was, however, significant heterogeneity in the
association between ITN household ownership and parasitemia
prevalence (I
2=73.5%, p,0.01). The pooled effect on the
prevalence of parasitemia of children sleeping under an ITN the
previous night (Figure 1B) was of a similar magnitude (relative
reduction of 24%, 95% CI 1%–42%; I
2=79.5%, p,0.001) and
not significantly different from the pooled effect on parasitemia of
ITN ownership (p.0.05).
Figure 2 shows the results ofthe analysisof theeffect ofhousehold
ownership of at least one ITN on child mortality. In the individual
surveys, there were statistically significant reductions in five surveys:
Zambia 2001–2002 with a 69% RR reduction in child mortality
(95% CI 24%–87%); Kenya 2008–2009 with a 68% RR reduction
(95% CI 29%–86%); Rwanda 2007–2008 with a 55% RR
reduction (95% CI 28%–72%); Niger 2006 with a 41% RR
reduction (95% CI 14%–59%); and Madagascar 2008 with a 30%
RR reduction (95% CI 2%–50%). Across the 29 surveys, there was
a statistically significant pooled RR reduction in child mortality of
23% (95% CI 13%–31%) with the effect being consistent across the
29 surveys (I
2=25.6%, p.0.05 for the I
2 value). Restricting the
analysis of ITN ownership on child mortality to observations in the
1 y prior to the survey, and thereby reducing the influence of recall
bias, did not markedly change the estimated mean effect of ITN
ownership (unpublished data).
Tables 3 and 4 show results of the logistic regression of ITN
household ownership and use in children under-five on parasit-
emia by malaria transmission risk. The effect of ITN household
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Country Survey
Year of
Survey n Households
Percent Households in
Transmission Area
Household ITN
Ownership (%) Survival Analysis
High Medium Low
n Months of
Observation n Deaths
Benin DHS 2001 5,769 86.4 13.0 0.6 3.7 143,784 274
Benin DHS 2006 17,511 100.0 0.0 0.0 35.3 478,667 691
Burkina Faso DHS 2003 9,097 99.0 1.0 0.0 9.5 289,592 681
Cameroon DHS 2004 10,462 71.3 28.4 0.3 5.8 18,635 32
Congo DHS 2005 5,879 100.0 0.0 0.0 8.0 133,967 185
DRC DHS 2007 8,886 68.4 27.1 4.5 11.5 252,993 474
Eritrea DHS 2002 9,824 0.0 64.7 35.3 3.6 226,380 168
Ethiopia DHS 2005 13,721 0.0 38.7 61.3 3.5 306,171 355
Ghana DHS 2008 11,778 79.3 16.0 4.7 39.5 90,434 75
Kenya DHS 2003 8,561 3.1 33.6 64.3 8.9 175,527 236
Madagascar DHS 2003–2004 4,223 18.3 81.7 0.0 2.2 153,711 124
Madagascar DHS 2008–2009 17,857 18.5 73.1 8.4 42.9 345,757 238
Malawi DHS 2004–2005 13,664 57.0 42.8 0.2 27.6 302,931 487
Mali DHS 2006 12,998 70.4 25.2 4.4 47.1 403,769 892
Namibia DHS 2006–2007 9,200 0.0 51.5 48.5 15.6 153,299 137
Niger DHS 2006 7,660 0.0 90.6 9.4 50.3 274,681 608
Nigeria DHS 2003 7,225 80.9 19.1 0.0 1.9 166,309 427
Nigeria DHS 2008 34,070 79.8 20.0 0.2 10.7 833,164 1,659
Rwanda DHS 2000 9,696 0.0 88.0 12.0 1.5 325,703 547
Rwanda DHS 2005 10,272 3.5 52.6 43.9 15.9 248,787 425
Rwanda DHS 2007–2008 7,377 1.6 58.2 40.2 50.5 154,988 143
STP DHS 2008–2009 3,536 0.0 100.0 0.0 34.8 47,810 20
Sierra Leone DHS 2008 7,284 83.3 13.5 3.2 32.8 163,408 264
Tanzania DHS 2004–2005 9,735 16.4 57.0 26.6 25.9 245,829 301
Uganda DHS 2006 8,870 30.6 65.7 3.7 19.1 240,116 385
Zambia DHS 2001–2002 7,126 16.1 83.9 0.0 12.4 298,866 517
Zambia DHS 2007 7,164 0.2 99.8 0.0 54.2 184,023 251
Zimbabwe DHS 2005–2006 9,285 0.0 22.0 78.0 6.9 162,615 171
DRC, Democratic Republic of Congo; STP, Sa ˜oT o m e ´ &P r ı ´ncipe.
doi:10.1371/journal.pmed.1001091.t001
Table 2. Characteristics of surveys included in the analysis of parasitemia prevalence.
Country Survey
Year of
Survey
n House-
holds
Percent Households in
Transmission Area
ITN Coverage
Indicators (%)
Child Parasitemia
Measurements
High Medium Low Ownership Use Total n Positive
Angola MIS 2006–2007 2,599 45.0 53.0 2.0 26.6 17.7 1,263 276
Liberia MIS 2008–2009 4,162 91.2 0.0 8.8 41.7 26.4 1,296 419
Rwanda DHS 2007–2008 7,377 1.6 58.2 40.2 50.5 55.7 2,509 67
Senegal MIS 2008–2009 9,291 0.0 97.3 2.7 57.5 23.0 3,702 238
Tanzania MIS 2007–2008 8,497 23.3 42.3 34.4 44.5 25.7 5,680 712
Uganda MIS 2009–2010 4,421 37.0 59.8 3.2 42.5 32.8 2,108 852
Zambia MIS 2006 2,999 21.5 78.0 0.5 44.4 22.8 947
a 203
a
aParasitemia measurements were available for 1,817 children with 380 testing positive, but only 947 children’s slide data could be properly linked to their respective
household’s bednet information.
doi:10.1371/journal.pmed.1001091.t002
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same across the three levels of transmission risk (p.0.05). In
general, wet season, increasing child age, lower maternal
education, and lower household wealth were significantly
associated with higher odds of parasitemia (Tables 3 and 4).
Table 5 shows the result of the Cox Proportional Hazards model
Figure 1. Effect of (A) ITN household ownership; and (B) ITN use in children under five, on prevalence of parasitemia.
doi:10.1371/journal.pmed.1001091.g001
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level. There were no statistically significant differences in the effect
of ITNs on child mortality by malaria transmission level (p.0.05).
In general, wet season, shorter birth intervals, a multiple birth,
older maternal age, lower maternal education, lower household
wealth, fewer household members, lower coverage of other
childhood immunization, and skilled birth attendance were
associated with higher probability of child mortality (Table 5).
All the relationships observed between child mortality and
parasitemia and the covariates controlled for are as expected
and support the validity of the analytical approach.
We did not observe statistically significant differences in the
effect of the number of ITNs per household member for either
parasitemia prevalence or child mortality when stratified by
transmission level (Figure 3; p.0.05). We found a statistically
significant association between ITNs and child mortality in urban
areas with high and medium levels of malaria transmission
(Figure 4); however, we did not observe statistically significant
differences in the effect of ITNs in rural versus urban areas when
stratified by transmission level (Figure 4; p.0.05).
Discussion
Our findings from a large number of countries suggest that the
rapid scale-up in ITN coverage observed in several sub-Saharan
African countries has likely been accompanied by reductions in
child mortality. Our results are also highly consistent with findings
from previous RCTs. We found a 23% (95% CI 13%–31%)
pooled relative reduction in child mortality across 29 surveys
compared to the pooled 18% (95% CI 10%–25%) relative
reduction observed in three RCTs [3]. For parasitemia, we found
a 20% (3%–35%) reduction across seven surveys, which is not
statistically distinguishable from the pooled 13% reduction
observed in seven RCTs [4]. The lack of a major difference
Figure 2. Effect of ITN household ownership on all-cause mortality among children 1 mo to 59 mo of age.
doi:10.1371/journal.pmed.1001091.g002
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the intention to treat analysis used in RCTs, although ITN
coverage in the RCTs was almost universal. It is also important to
note that the RCTs targeted provision of ITNs across all age
groups, while the scale-up in most sub-Saharan African countries
has initially focused on children and pregnant women.
Our results are also consistent and statistically indistinguishable
from previous observational studies of ITNs on child mortality. A
cohort study in Kenya found a 44% (4%–67%) relative reduction
in mortality among children age 1 mo to 59 mo associated with
ITN use [8]. A case-control study in Tanzania found a 27% (95%
CI 3%–45%) relative reduction in mortality among children aged
Table 3. Results from the logistic regression of ITN household ownership on parasitemia prevalence by malaria transmission risk.
Indicator High Medium Low
OR p-Value 95% CI OR p-Value 95% CI OR p-Value 95% CI
ITN ownership 0.94 0.404 (0.81–1.09) 0.76 0.000 (0.67–0.87) 0.72 0.314 (0.38–1.37)
Seasonality Dry 1.00 — 1.00 1.00 — — 1.00 — —
Wet 1.14 0.199 (0.94–1.38) 1.89 0.000 (1.61–2.23) 3.48 0.008 (1.39–8.70)
Child’s age (y) 0–1 1.00 — 1.00 1.00 — — 1.00 — —
2–3 2.26 0.000 (1.91–2.68) 1.90 0.000 (1.56–2.26) 1.75 0.170 (0.79–3.90)
4–5 2.47 0.000 (2.02–3.02) 2.34 0.000 (1.95–2.81) 2.12 0.140 (0.78–5.72)
Maternal education None 1.00 — 1.00 1.00 — — 1.00 — —
Primary 0.79 0.004 (0.67–0.92) 0.87 0.107 (0.74–1.03) 4.43 0.002 (1.77–11.1)
$Secondary 0.61 0.002 (0.44–0.83) 0.55 0.000 (0.39–0.76) 1.06 0.934 (0.29–3.81)
Household wealth
(quintiles)
Poorest 1.00 — 1.00 1.00 — — 1.00 — —
Quintile 2 1.27 0.013 (1.05–1.54) 0.75 0.001 (0.63–0.89) 0.71 0.580 (0.21–2.38)
Quintile 3 0.82 0.073 (0.65–1.02) 0.51 0.000 (0.42–0.61) 0.69 0.511 (0.23–2.06)
Quintile 4 0.63 0.001 (0.48–0.83) 0.50 0.000 (0.41–0.62) 0.58 0.340 (0.19–1.83)
Richest 0.31 0.000 (0.21–0.46) 0.36 0.000 (0.26–0.49) 0.59 0.362 (0.19–1.83)
Urban residence Rural 1.00 — 1.00 1.00 — — 1.00 — —
Urban 0.70 0.002 (0.56–0.88) 0.40 0.000 (0.30–0.53) 0.46 0.196 (0.14–1.50)
doi:10.1371/journal.pmed.1001091.t003
Table 4. Results from the logistic regression of ITN use in children under five on prevalence of parasitemia by malaria transmission
risk.
Indicator High Medium Low
OR p-Value 95% CI OR p-Value 95% CI OR p-Value 95% CI
ITN use 0.91 0.315 (0.77–1.09) 0.75 0.000 (0.64–0.88) 0.95 0.902 (0.45–2.02)
Seasonality Dry 1.00 — 1.00 1.00 — — 1.00 — —
Wet 1.08 0.531 (0.86–1.35) 1.93 0.000 (1.60–2.31) 4.05 0.013 (1.35–12.2)
Child’s age (y) 0–1 1.00 — 1.00 1.00 — — 1.00 — —
2–3 2.27 0.000 (1.86–2.76) 1.76 0.000 (1.47–2.10) 1.23 0.645 (0.51–2.95)
4–5 2.29 0.000 (1.81–2.90) 2.46 0.000 (1.99–3.04) 1.25 0.687 (0.42–3.78)
Maternal educationNone 1.00 — 1.00 1.00 — — 1.00 — —
Primary 0.76 0.004 (0.62–0.91) 0.87 0.150 (0.71–1.05) 4.48 0.003 (1.66–12.0)
$Secondary 0.51 0.001 (0.35–0.75) 0.54 0.001 (0.37–0.79) 0.85 0.818 (0.21–3.46)
Household wealth
(quintiles)
Poorest 1.00 — 1.00 1.00 — — 1.00 — —
Quintile 2 1.31 0.022 (1.04–1.64) 0.82 0.053 (0.67–1.00) 0.47 0.295 (0.11–1.94)
Quintile 3 0.80 0.097 (0.62–1.04) 0.58 0.000 (0.46–0.72) 0.61 0.384 (0.20–1.84)
Quintile 4 0.70 0.026 (0.51–0.96) 0.56 0.000 (0.43–0.72) 0.47 0.210 (0.14–1.53)
Richest 0.34 0.000 (0.22–0.53) 0.39 0.000 (0.27–0.57) 0.24 0.058 (0.21–3.46)
Urban residence Urban 1.00 — 1.00 1.00 — — 1.00 — —
Rural 0.67 0.003 (0.52–0.88) 0.36 0.000 (0.26–0.51) 0.39 0.187 (0.09–1.59)
doi:10.1371/journal.pmed.1001091.t004
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age by malaria transmission risk.
Indicator High Medium Low
RR p-Value 95% CI RR p-Value 95% CI RR p-Value 95% CI
ITN ownership 0.82 0.001 (0.73–0.93) 0.81 0.003 (0.70–0.93) 0.74 0.094 (0.53–1.05)
Seasonality Dry 1.00 — — 1.00 — — 1.00 — —
Wet 0.98 0.590 (0.93–1.05) 0.95 0.185 (0.88–1.02) 0.89 0.280 (0.72–1.10)
Child’s sex Male 1.00 — — 1.00 — — 1.00 — —
Female 0.98 0.463 (0.93–1.03) 0.92 0.004 (0.87–0.97) 0.94 0.358 (0.84–1.07)
Birth interval (mo) ,12 1.00 — — 1.00 — — 1.00 — —
12–23 0.84 0.150 (0.66–1.07) 0.82 0.114 (0.64–1.05) 0.85 0.526 (0.51–1.41)
$24 0.55 0.000 (0.44–0.70) 0.58 0.000 (0.46–0.74) 0.53 0.013 (0.32–0.87)
Birth order First 1.00 — — 1.00 — — 1.00 — —
$Second 0.90 0.014 (0.84–0.98) 0.94 0.184 (0.85–1.03) 0.68 0.000 (0.56–0.82)
Birth type Single 1.00 — — 1.00 — — 1.00 — —
Multiple 2.34 0.000 (2.09–2.61) 2.23 0.000 (1.95–2.55) 2.47 0.000 (1.84–3.31)
Maternal age (y) 15–19 1.08 0.321 (0.93–1.26) 0.98 0.780 (0.82–1.16) 0.92 0.651 (0.65–1.31)
20–24 1.07 0.128 (0.98–1.18) 0.91 0.066 (0.82–1.01) 0.69 0.001 (0.55–0.85)
25–29 1.05 0.266 (0.97–1.13) 0.91 0.031 (0.83–0.99) 0.74 0.001 (0.62–0.89)
30–34 1.00 — — 1.00 — — 1.00 — —
35–39 1.10 0.040 (1.00–1.20) 1.04 0.428 (0.94–1.15) 1.01 0.908 (0.83–1.24)
40–44 0.99 0.821 (0.88–1.11) 1.10 0.144 (0.97–1.24) 1.22 0.099 (0.96–1.55)
45–49 1.15 0.092 (0.98–1.34) 1.30 0.004 (1.09–1.55) 0.98 0.923 (0.66–1.45)
Maternal education None 1.00 — — 1.00 — — 1.00 — —
Primary 0.95 0.177 (0.89–1.02) 0.97 0.391 (0.90–1.04) 0.84 0.033 (0.72–0.99)
$Second. 0.66 0.000 (0.59–0.73) 0.69 0.000 (0.61–0.78) 0.55 0.000 (0.43–0.70)
n household
members
#4 1.00 — — 1.00 — — 1.00 — —
5–8 0.85 0.000 (0.80–0.91) 0.75 0.000 (0.70–0.81) 0.83 0.016 (0.72–0.97)
$9 0.89 0.002 (0.83–0.96) 0.73 0.000 (0.67–0.80) 0.72 0.001 (0.59–0.88)
Household wealth
(quintiles)
Poorest 1.00 — — 1.00 — — 1.00 — —
Quintile 2 1.01 0.698 (0.94–1.09) 1.07 0.150 (0.98–1.16) 1.01 0.917 (0.84–1.22)
Quintile 3 1.00 0.939 (0.92–1.08) 1.00 0.972 (0.91–1.10) 1.03 0.783 (0.85–1.24)
Quintile 4 0.95 0.312 (0.87–1.05) 1.06 0.249 (0.96–1.17) 0.92 0.404 (0.75–1.12)
Richest 0.74 0.000 (0.65–0.85) 0.81 0.002 (0.71–0.92) 0.76 0.040 (0.59–0.99)
Urban residence Rural 1.00 — — 1.00 — — 1.00 — —
Urban 0.91 0.017 (0.84–0.98) 1.03 0.556 (0.93–1.14) 1.17 0.135 (0.95–1.44)
PSU-SBA coverage 0.88 0.025 (0.78–0.98) 0.76 0.001 (0.65–0.89) 0.99 0.931 (0.72–1.36)
PSU-DPT3 coverage 0.70 0.000 (0.61–0.81) 0.56 0.000 (0.48–0.65) 0.69 0.021 (0.51–0.95)
Calendar year 1997 1.82 0.253 (0.65–5.09) 3.05 0.000 (2.49–3.73) 3.23 0.000 (1.82–5.71)
1998 2.86 0.000 (1.92–4.28) 2.25 0.000 (1.89–2.69) 2.71 0.000 (1.61–4.55)
1999 1.87 0.001 (1.31–2.65) 1.35 0.000 (1.17–1.57) 1.30 0.223 (0.85–1.99)
2000 1.00 — — — — — — — —
2001 0.81 0.003 (0.70–0.93) 0.52 0.000 (0.44–0.62) 0.89 0.534 (0.62–1.28)
2002 0.83 0.009 (0.72–0.95) 0.35 0.000 (0.29–0.42) 0.64 0.017 (0.45–0.92)
2003 0.78 0.002 (0.66–0.91) 0.38 0.000 (0.31–0.46) 0.66 0.032 (0.45–0.97)
2004 0.75 0.002 (0.62–0.90) 0.32 0.000 (0.26–0.40) 0.64 0.025 (0.44–0.95)
2005 0.72 0.001 (0.60–0.88) 0.30 0.000 (0.24–0.37) 0.66 0.056 (0.44–1.01)
2006 0.72 0.001 (0.59–0.88) 0.29 0.000 (0.22–0.37) 0.58 0.027 (0.35–0.94)
2007 0.75 0.009 (0.60–0.93) 0.30 0.000 (0.22–0.39) 0.75 0.308 (0.43–1.30)
2008 0.69 0.003 (0.54–0.88) 0.27 0.000 (0.19–0.37) 0.56 0.156 (0.25–1.25)
Child age in months was included as analysis time. Both calendar year and seasonality were allowed to vary analysis time.
DPT3, three-dose diphtheria, pertussis and tetanus.
doi:10.1371/journal.pmed.1001091.t005
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stratified by number of ITNs per household member (,0.25 ITNs per household member, $0.25 ITNs per household member) and
malaria transmission risk (high, medium, low).
doi:10.1371/journal.pmed.1001091.g003
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PLoS Medicine | www.plosmedicine.org 9 September 2011 | Volume 8 | Issue 9 | e1001091Figure 4. Effect of ITN ownership on (A) prevalence of parasitemia; and (B) all-cause mortality among children 1 mo to 59 mo of
age, stratified by area of residence (urban or rural) and malaria transmission risk (high, medium, low).
doi:10.1371/journal.pmed.1001091.g004
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existing literature by providing evidence of the effect of ITNs on
health outcomes under routine conditions over a much broader
range of transmission levels and countries; previous studies were
predominantly in high endemicity areas. Overall, this finding
suggests that on average at least, ITNs have a similar and sizeable
effect on health outcomes under routine use compared to that seen
in efficacy trials.
This finding supports the continued scale-up of ITNs in sub-
Saharan Africa, such as the more recent efforts in Nigeria and
Democratic Republic of Congo that had previously low levels of
ITN coverage and large populations at risk of malaria [1]. It also
emphasizes the importance of ongoing and future efforts to
maintain coverage of ITNs in those countries with successful scale-
ups by replacing worn out ITNs. Furthermore, it also suggests that
the massive effort to scale up ITN coverage over the past decade
has paid off and that it is possible for health systems to increase
coverage of interventions and affect health outcomes over a
relatively short period of time. Continued coordinated efforts
between local and national governments, international organiza-
tions, funding agencies, and researchers are needed to ensure that
ITNs are reaching all populations at risk of malaria. With the
relatively large impact of ITNs on child mortality, our findings also
support the continued emphasis on malaria control more
generally, including the push towards malaria elimination, as a
way of improving child health in endemic countries.
We found no evidence of substantial heterogeneity in the effect
of ITNs on child mortality across the countries studied here. On
the other hand, we found evidence of heterogeneity in the
association between ITNs and parasitemia prevalence across
countries. One possible explanation is because parasitemia may
persist for some time after initial malaria infection; this
heterogeneity may reflect different levels of malaria transmission
intensity. That is, in high transmission areas, parasitemia may be
so prevalent that it is a poor indicator of the incidence of malaria.
This heterogeneity in the effect of ITNs on parasitemia prevalence
is an important topic for future investigation. We were also not
able to detect a significantly different effect on parasitemia of
children sleeping under an ITN compared to just household
ownership of an ITN; this may simply reflect limited statistical
power to detect a true difference. However, we must examine
other possible explanations. One possible explanation is that even
though MIS data collection is designed to be in high transmission
seasons, some of the data collection does occur in low transmission
seasons and as the MIS only record information about sleeping
under an ITN for the previous night, use of ITNs by children
during the low transmission season may not be indicative of use in
high transmission seasons. Mothers responding to a question by
interviewers about whether their child slept under an ITN the
previous night may also be more likely to respond in the positive
because of social pressure.
In our study we were not able to detect significant differences in
the effect of ITNs by transmission level, number of ITNs owned
per household member, or urban and rural residence. These
findings likely reflect inadequate power, as indicated by the width
of the confidence intervals, to detect statistically significant
differences. A previous meta-analysis of RCTs suggested that the
efficacy of ITNs is lower in areas with higher malaria transmission
[4], while an observational study from rural Kenya [8] found
greater effects in areas of high malaria transmission. In our pooled
analysis we found significant effects of ITNs in urban areas, which
supports previous studies that have shown significant impacts of
ITNs on malaria outcomes in urban areas [27,28]. We were also
able to detect significant impacts of ITNs in only a limited number
of individual surveys because of small sample sizes, and in general,
we did not have the power to detect significant differences between
surveys. On the basis of our analysis we cannot discount the
possibility that the effect of ITNs varies by these and other factors,
such as the extent of education on the proper use of ITNs that are
accompanied with distribution programs. Given the large
investments in malaria control over the past 10 y, future research
and better ways to monitor how the impact of malaria control
interventions might vary across populations are required.
Our study provides a method for understanding the real-world
impact of not only ITNs but also other interventions on health
outcomes using data that are routinely collected. There are,
however, a number of limitations of our analysis. First, several
MIS do not specify whether the parasitemia tests were based on
microscopy or rapid diagnostic test (RDT), and as a result we were
not able to standardize the parasitemia measurements. Second,
our analysis was limited to publically available datasets; therefore
we were not able to access the full range of MIS that have been
conducted, although steps are being taken to make these data
more widely accessible (e.g., www.malariasurveys.org). Third, in
our analysis of parasitemia, we were limited to a cross-sectional
analysis and were therefore not able to determine whether ITN
exposure occurred prior to malaria infection. Fourth, we were only
able to examine the relationship between ITNs and all-cause
mortality as the surveys we used do not include information on
cause-specific mortality. Increased use of verbal autopsy may allow
for refined assessment of the impact of ITNs on malaria-specific
mortality, although concerns have been raised about the predictive
power of verbal autopsy for malaria [29]. Sixth, the DHS do not
collect information on skilled birth attendance and immunizations
for children who have died, so in our analysis we could only
control for use of these interventions at the PSU level. Seventh, we
were not able to control for the effect of other malaria
interventions such as indoor residual spraying or drug treatment.
Finally, our analysis, like others based on observational studies,
may be prone to residual confounding that has not been controlled
for by the methods used.
Monitoring and evaluation of interventions to improve
population health must include not only measurement of
utilization but also whether the delivery of the intervention at
scale results in real-world changes in health outcomes. The latter is
critical if we are to understand whether interventions are being
delivered and used correctly. We used routinely collected survey
data to assess the association between intervention use and health
outcomes across a large number of countries. Our results suggest
that, on average, the scale-up of ITNs in sub-Saharan Africa has
led to significant reductions in child mortality—comparable to
those found in previous RCTs. While further work is needed to
elucidate possible variations in the effect of ITNs, these findings
add to the body of evidence that ITNs are effective under usual
program conditions and support the continued efforts to scale-up
ITN coverage in sub-Saharan Africa.
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Background. Malaria is a major public health problem. Half
the world’s population is at risk of this parasitic disease,
which kills a million people (mainly children living in sub-
Saharan Africa) every year. Malaria is transmitted to people
through the bites of infected night-flying mosquitoes. Soon
after entering the human body, the parasite begins to
replicate in red blood cells, bursting out every 2–3 days and
infecting more red blood cells. The presence of the para-
site in the bloodstream (parasitemia) causes malaria’s
characteristic fever and can cause fatal organ damage.
Malaria can be prevented by controlling the mosquitoes that
spread the parasite and by owning and sleeping under
insecticide-treated nets (ITNs) to avoid mosquito bites. In
trials, ITN use reduced parasitemia in young children by
about 13% and deaths among children by about 18%.
Consequently, the widespread provision of ITNs is a mainstay
of the World Health Organization’s efforts to control malaria,
and in 2005 the World Health Assembly agreed a target of
providing ITNs for 80% of the people at risk of malaria by
2010.
Why Was This Study Done? Although progress towards
this goal has been variable, several sub-Saharan African
countries have rapidly scaled up the fraction of households
that own ITNs from near zero to more than 60% with the
support of international donors. But has this scale-up of ITN
coverage been accompanied by improvements in health
outcomes similar to those seen in the trials of ITNs? ITNs may
not work as well under routine conditions as in trials because
of, for example, the use of nets that are no longer
impregnated with active insecticide; nets have to be
retreated regularly with insecticide to maintain their
protection against mosquitoes. Unfortunately, in many
countries in sub-Saharan Africa, health information systems
are weak and incomplete records of deaths are kept, which
makes it impossible to determine the rates of malaria-
specific morbidity (illness) and mortality (deaths) accurately.
In this study, the researchers use data collected in household
surveys to examine the association between ITN ownership
in a number of sub-Saharan African countries and two
specific outcomes—the proportion of the population with
parasitemia, and child mortality.
What Did the Researchers Do and Find? The researchers
used a statistical method to assess the association between
household ITN ownership or use in young children and the
prevalence of parasitemia among children using data from a
set of household surveys. They looked specifically at the
relationship between ITN household ownership and child
mortality using data from 29 surveys undertaken in 22 sub-
Saharan African countries. They then pooled the results of
the individual surveys. The pooled relative reduction in
parasitemia prevalence among children associated with
household ownership of at least one ITN was 20%. That is,
averaged out over the countries studied, household ITN
ownership was associated with a reduction of around a fifth
in the prevalence of parasitemia. The pooled relative
reduction of parasitemia prevalence associated with
children sleeping under an ITN was 24%. Finally, the
pooled relative reduction in mortality between 1 month
and 5 years old associated with household ITN ownership
was 23%.
What Do These Findings Mean? These findings suggest
that the rapid scale-up in ITN coverage that has occurred in
several sub-Saharan African countries has been accompanied
by significant reductions in child deaths. Importantly, these
findings are highly consistent with those from trials of ITNs.
The accuracy of these findings may be affected by some
aspects of the study design. For example, because the study
uses observational data, it is possible that people who own
ITNs share other characteristics that are actually responsible
for the reduction in parasitemia prevalence and childhood
deaths. Nevertheless, these findings add to the body of
evidence that ITNs are effective in routine use. Thus, they
support continued efforts to scale-up ITN coverage in sub-
Saharan Africa and highlight the importance of maintaining
ITN coverage in countries that have already successfully
scaled up coverage.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001091.
N The Institute for Health Metrics and Evaluation provides
visualizations and datasets for a range of global health
indicators including child mortality and insecticide treated
bed net coverage
N Information is available from the World Health Organiza-
tion on malaria (in several languages); the 2010 World
Malaria Report provides details of the current global
malaria situation
N The US Centers for Disease Control and Prevention provide
information on malaria and on insecticide-treated bed nets
N The Roll Back Malaria Partnership provides information on
the global control of malaria, malaria in Africa and
insecticide-treated bed nets, and access to Malaria
Indicator Survey datasets
N Information is also available about the Demographic and
Health Surveys
N MedlinePlus provides links to additional information on
malaria (in English and Spanish)
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